Rankings
▼
Calendar
CCEL Q2 2016 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena
CCEL
Cryo-Cell International, Inc.
$25M
Q2 2016 Earnings
Healthcare
Medical - Care Facilities
Income Statement
Revenue
$6M
Gross Profit
$4M
75.2% margin
Operating Income
$882,384
15.3% margin
Net Income
$637,132
11.0% margin
EPS (Diluted)
$0.07
QoQ Revenue Growth
+12.1%
Cash Flow
Operating Cash Flow
$1M
Free Cash Flow
$981,890
Stock-Based Comp.
$135,802
Balance Sheet
Total Assets
$20M
Total Liabilities
$25M
Stockholders' Equity
-$5M
Cash & Equivalents
$5M
Revenue Segments
Umbilical Cord Blood And Cord Tissue Stem Cell Service
$5M
99%
Prepacyte-CB
$66,379
1%
← FY 2016
All Quarters
Q3 2016 →
